Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04385511
Other study ID # 2020PHB014-01
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 19, 2020
Est. completion date December 2020

Study information

Verified date May 2020
Source Peking University People's Hospital
Contact Hansheng Liang, MD
Phone 13717929362
Email doctorlianghsh@sina.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study assumed that supraglottic jet ventilation is an alternative solution as a safe way to do the preoxygenation before endotracheal intubation by contrasting it with mask pressurized ventilation. The investigators also expected that supraglottic jet ventilation won't increase the occurrence of esophageal reflux.


Description:

The study assumed that supraglottic jet ventilation is an alternative solution as a safe way to do the preoxygenation before endotracheal intubation by contrasting it with mask pressurized ventilation. The investigators also expected that supraglottic jet ventilation won't increase the occurrence of esophageal reflux.

The investigators randomly divided the patients into 2 groups:Group C and Group S.Patients in Group C will be preoxygenation with mask pressurized ventilation while patients in Group S with supraglottic jet ventilation by Wei NASAL JET(WNJ).The tracheal intubation will be done after the 3 minutes preoxygenation. The investigators will measure the PaCO2 before and after preoxygenation, and the investigators will take the stomach-ultrasonography to find if there are too much gas in the gastro. If pulse oximetry is lower than 95% during the preoxygenation, the investigators will adjust the position of the Wei NASAL JET(WNJ) or use the change the way that the investigators hold the mask or change the pressure of ventilation on the basis of the group.


Recruitment information / eligibility

Status Recruiting
Enrollment 68
Est. completion date December 2020
Est. primary completion date December 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 64 Years
Eligibility Inclusion Criteria:

- scheduled for any surgery under general anesthesia

- adults age range from 18-64 years old

- American Society of Anesthesiologists Physical Status Classification (ASA class) I-II

- voluntary participation in this clinical trail, signed informed consents

Exclusion Criteria:

- patients with epistaxis, rhinostenosis, the episodes of rhinitis, severe gastroesophageal reflux disease, severe respiratory disease, severe cardiovascular and cerebrovascular disease

- long-term use if anticoagulant drugs

- can't cooperate with intervention

- pulse oximetry <95% with normal respiration

Study Design


Related Conditions & MeSH terms


Intervention

Device:
supraglottic jet ventilation
patients who were randomized into supraglottic jet ventilation group would be placed Wei Nasal Jet Tube after conducted. Then they will get the supraglottic jet ventilation to make sure their pulse oximetry is over 95%. After 3 minutes, endotracheal intubation was performed via mouth approach.

Locations

Country Name City State
China Peking University People's Hospital Beijing Beijing

Sponsors (1)

Lead Sponsor Collaborator
Peking University People's Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary alveolar oxygen tension(PaO2) The results comes from blood gas analysis 3 minutes after preoxygenation
Primary alveolar oxygen tension(PaO2) The results comes from blood gas analysis baseline (before preoxygenation)
Secondary PaCO2 The results comes from blood gas analysis 3 minutes after preoxygenation
Secondary PaCO2 The results comes from blood gas analysis baseline (before preoxygenation)
Secondary gastric antrum cross section The results comes from the ultrasound of gastric 3 minutes after preoxygenation
Secondary gastric antrum cross section The results comes from the ultrasound of gastric baseline (before preoxygenation)
Secondary complications such as nasal bleeding, dry throat itching, sore throat, nausea and vomiting, pressure and other adverse reactions 1 day
See also
  Status Clinical Trial Phase
Completed NCT01018316 - UMOX - New Device for Oropharyngeal Preoxygenation N/A
Completed NCT03310723 - Pre-Oxygenation Techniques in Pregnancy N/A
Recruiting NCT04070404 - Quality of Preoxygenation in Emergency Surgery
Withdrawn NCT01232153 - Preoxygenation Before Prehospital Tracheal Intubation With NIV Versus Balloon N/A
Recruiting NCT05846919 - High Flow Oxygen in Preoxygenation During Rapid Sequence Induction in Infants and Small Children N/A
Completed NCT04010279 - Can we Improve Preoxygenation by Using Adjustable Pressure Limiting Valve (APL) ? N/A
Terminated NCT03240614 - PreOxygenation for EndoTracheal Intubations N/A
Completed NCT03087825 - Preoxygenation Method With a Calibrated Leak N/A
Not yet recruiting NCT04148443 - Impact of Preoxygenation Time on End-tidal Oxygen Concentration and on Hypoxic Events Occurring After Intubation in the Intensive Care Unit. N/A
Completed NCT02979067 - Improvement of Oxygenation During Apnoea by i-THRIVE N/A
Recruiting NCT03802643 - Preoxygenation Before General Anesthesia
Completed NCT04596215 - Benefit of the Oxygen Reserve Index for Control of Success of Preoxygenation in Adults
Completed NCT03772574 - Preoxygenation Using THRIVE Versus Facemask in Parturients N/A
Completed NCT03615417 - High-Flow Nasal Cannula (HFNC) Preoxygenation in Obese Patients Undergoing General Anesthesia N/A